Advances in Therapeutic Devices for Sleep Apnea (TechVision)

Technology Advances, Trends and Strategic Perspectives Reckoned to Boost the Adoption of Multiple Treatment Options

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The sleep apnea therapeutics market has witnessed constant growth in the last decade due to the penetration of conventional therapies in untapped regions of the world. However, it is the technological advancements that have led to the emergence of a number conventional therapies for sleep apnea treatment. Increasing patient non-compliance towards the conventional CPAP treatment has led to development of alternative treatments such as oral appliances, oral pressure therapy, neurostimulators, positional therapy devices, to name a few.This research service covers the scope of all the advancements in therapeutic devices for the treatment of sleep apnea. The research study covers the market share assessment of CPAPs, key innovators across all types of treatment devices and key drivers and challenges affecting this market.The research study further details the adoption of conventional modes of treatment in regions of North America, Europe and Asia-Pacific, explaining the healthcare structure and the likelihood of adoption of alternative treatment methods in these three regions of the world. Finally, the section on opportunity evaluation gives the reader a chance to understand the current status of the market, positioning of the newer alternatives and explore future possibilities.

Table of Contents

1.0 Executive Summary1.1 Scope of Research 1.2 Research Process Methodology1.2 Research Methodology (continued)1.3 Key Findings2.0 Technology Capability and Trends2.1 Obstructive Sleep Apnea Constitutes over 80% of the Sleep Apnea Cases2.2 High Marked Demand for a CPAP Alternative to Treat OSA2.3 Adoption of CPAPs Hit due to Patient Non-Compliance2.4 Over 80% of the CPAP Market Share is Owned by Two Companies2.5 CPAPs Expected to Dominate due to Lack of Comparative Clinical Studies2.6 ResMed Continues to Lead the CPAP Market with Their S9 Series2.7 Philips Respironics offers One of the Most Recent Advancements in CPAPs2.8 CPAP Non-compliance Leads Patients to Oral Device Therapy2.9 Oral Device Therapy is Effective in Reducing Overall Apnea Hypopnea Index2.10 Preference Towards Oral Device Therapy Increases as it Offers a Permanent Solution2.11 ApniCure’s Invention works on Negative Oral Pressure2.12 SomnoMed offers the largest range of Mandibular Advancement Devices2.13 NPD Efforts Focus on Stimulation of the Hypoglossal Nerve2.14 Device Miniaturization Expected to Boost the Neurostimulation Segment2.15 Nyxoah focuses on Device Miniaturization and Reduced Surgery Time2.16 Inspire Medical Systems Presents a Targeted Neurostimulation Therapy2.17 ImThera Medical Aims to Provide Permanent Freedom from CPAP Masks2.18 Non-invasive Offerings Expected to Cut Down Cost of Conventional Treatments2.19 Provent Sleep Therapy Offers a Novel Approach to Treat Obstructive Sleep Apnea2.20 Positional Therapy from Advanced Brain Monitoring Provides a New Approach to Treat OSA2.21 Surgical Interventions Imperative for Severe OSA Cases2.22 Assessment of Surgery in Comparison to CPAPs and OAs3.0 Impact Assessment and Analysis3.1 Drivers and Challenges Shaping the Sleep Apnea Treatment Market3.2 Advancements in Technology Leading to a Rise in Alternative Therapies for OSA Treatment3.3 Poor Patient Compliance with Conventional Therapies is the Biggest Obstacle in the Sleep Apnea Market4.0 Diffusion of Innovations4.1 Reimbursements Models Need to be More Favorable Globally to Promote Adoption4.2 North American Market Remains the Top Consumer of Sleep Apnea Therapies5.0 IP Landscape5.1 ResMed and Philips Respironics Continue to Rule the CPAP Market5.2 Inspire Medical Systems Leads the Patent Filings in the Neurostimulation Segment5.3 Oral Appliances Witness Continued Trends in Patent Applications5.4 Surgery Options Witness a Slow Response in Patent Filings5.5 USA Generates Maximum Interest in Novel Technologies, as Demonstrated by the Trend in Patent Applications6.0 Opportunity Evaluation6.1 Adherence Tracking is Crucial to Improve Patient Compliance with Devices6.2 Telemedicine to Help Improve the Quality of Sleep7.0 Key Contacts and Patents7.1 Global Patents7.1 Global Patents (continued)7.1 Global Patents (continued)7.1 Global Patents (continued)7.2 Key ContactsLegal Disclaimer8.0 The Frost & Sullivan StoryThe Journey to Visionary Innovation8.1 The Frost & Sullivan Story8.2 Value Proposition: Future of Your Company & Career8.3 Global Perspective8.4 Industry Convergence8.5 360º Research Perspective8.6 Implementation Excellence8.7 Our Blue Ocean Strategy




Keyword1
global sleep apnea
Keyword2
sleep apnea therapeutics
Keyword3
global sleep apnea

Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.